Home > Annual Financials > LACTOSE (INDIA)

LACTOSE (INDIA) Financial Statement Analysis
[BOM: 524202]

The Revenues of LACTOSE (INDIA) have increased by 2.20% YoY .
The Earnings Per Share (EPS) of LACTOSE (INDIA) has decreased by -23.93 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

LACTOSE (INDIA) Last 5 Annual Financial Results
[BOM: 524202]

StandaloneMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹116 Cr₹114 Cr₹66 Cr₹46 Cr₹35 Cr
Expenses ₹100 Cr₹95 Cr₹54 Cr₹34 Cr₹29 Cr
Operating Profit (Excl OI) ₹17 Cr₹19 Cr₹11 Cr₹12 Cr₹6.22 Cr
Other Income ₹1.54 Cr₹1.15 Cr₹0.72 Cr₹0.58 Cr₹0.31 Cr
Interest ₹6.10 Cr₹5.25 Cr₹5.95 Cr₹5.12 Cr₹5.45 Cr
Depreciation ₹5.39 Cr₹5.22 Cr₹4.69 Cr₹4.56 Cr₹4.36 Cr
Profit Before Tax ₹6.92 Cr₹9.66 Cr₹1.46 Cr₹3.17 Cr₹-3.27 Cr
Profit After Tax ₹5.16 Cr₹6.79 Cr₹1.21 Cr₹2.45 Cr₹-2.48 Cr
Earnings Per Share (Rs)₹4.10₹5.39₹0.96₹1.95₹-2.17
PAT Margin (%)4.445.961.845.34-7.09
ROE(%)10.4015.493.036.65-7.21
ROCE(%)13.0118.189.2710.212.81
Total Debt/Equity(x)1.080.810.951.061.34

Key Financials

Market Cap : ₹ 134.9 Cr
Revenue (TTM) : ₹ 126.5 Cr
Net Profit(TTM) : ₹ 4.4 Cr
EPS (TTM) : ₹ 3.5
P/E (TTM) : 30.7

Industry Peers & Returns1W1M1Y
LACTOSE (INDIA) -3.4% -9.6% -38.1%
SUN PHARMACEUTICAL INDUSTRIES 1.4% 3.5% -5.9%
DIVIS LABORATORIES -3.9% 6.6% 15.2%
CIPLA 0.8% 0.2% -5.5%
TORRENT PHARMACEUTICALS 7% 7.8% 19.8%
DR REDDYS LABORATORIES 0.9% -2.8% -5.8%
MANKIND PHARMA -6.3% -10.5% -17.6%
ZYDUS LIFESCIENCES -3.6% -5.8% -4.3%
LUPIN -1.1% 0.9% -8.8%


LACTOSE (INDIA) Revenues
[BOM: 524202]

Y-o-Y

2.20 %

5 Yr CAGR

35.08 %

Years Revenues % Change
Mar2025 ₹116 Cr
2.20
Mar2024 ₹114 Cr
73.10
Mar2023 ₹66 Cr
43.22
Mar2022 ₹46 Cr
31.39
Mar2021 ₹35 Cr -


LACTOSE (INDIA) Operating Profit
[BOM: 524202]

Y-o-Y

-11.12 %

5 Yr CAGR

28.32 %

Years Operating Profit % Change
Mar2025 ₹17 Cr
-11.12
Mar2024 ₹19 Cr
66.82
Mar2023 ₹11 Cr
-7.20
Mar2022 ₹12 Cr
97.04
Mar2021 ₹6.22 Cr -

Operating Margins
Y-o-Y

-13.08 %

5 Yr CAGR

-5.01 %

Years Operating Margin% % Change
Mar2025 14.49%
-13.08
Mar2024 16.67%
-3.59
Mar2023 17.29%
-35.22
Mar2022 26.69%
49.94
Mar2021 17.8% -

LACTOSE (INDIA) Profit After Tax
[BOM: 524202]

Y-o-Y

-23.95 %

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2025 ₹5.16 Cr
-23.95
Mar2024 ₹6.79 Cr
461.54
Mar2023 ₹1.21 Cr
-50.67
Mar2022 ₹2.45 Cr
Positive
Mar2021 ₹-2.48 Cr -

PAT Margins
Y-o-Y

-25.50 %

5 Yr CAGR

Positive

Years PAT Margin(%) % Change
Mar2025 4.44 %
-25.50
Mar2024 5.96 %
223.91
Mar2023 1.84 %
-65.54
Mar2022 5.34 %
Positive
Mar2021 -7.09 % -

LACTOSE (INDIA) Earnings Per Share (EPS)
[BOM: 524202]

Y-o-Y

-23.93 %

5 Yr CAGR

Positive

Years EPS % Change
Mar2025 ₹4.10
-23.93
Mar2024 ₹5.39
461.46
Mar2023 ₹0.96
-50.77
Mar2022 ₹1.95
Positive
Mar2021 ₹-2.17 -

LACTOSE (INDIA) Return on Capital Employed (ROCE)
[BOM: 524202]

Y-o-Y

-28.44 %

5 Yr CAGR

46.69 %

Years ROCE % Change
Mar2025 13.01%
-28.44
Mar2024 18.18%
96.12
Mar2023 9.27%
-9.21
Mar2022 10.21%
263.35
Mar2021 2.81% -

LACTOSE (INDIA) Share Price vs Sensex

Current Share Price : ₹107.1
Current MarketCap: ₹ 134.9 Cr
Updated EOD on :Nov 12,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

-3.4%

-9.6%

-38.1%

SENSEX

1.2%

2.8%

6.3%

LACTOSE (INDIA) related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about LACTOSE (INDIA) Financials


How the annual revenues of LACTOSE (INDIA) have changed ?

The Revenues of LACTOSE (INDIA) have increased by 2.20% YoY .

How the Earnings per Share (EPS) of LACTOSE (INDIA) have changed?

The Earnings Per Share (EPS) of LACTOSE (INDIA) has decreased by -23.93 % YoY .